| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.003 |